Finally, analysis of fold changes between activated and resting conditions revealed a significantly reduced induction of Flt3L, IL-18R1, IL2, IL4, TGF-β1, TNFSF14, and TRANCE in MG patients at their first visit compared to follow-up (Figure 7D). This evidence concerns the gene IL18R1 and myasthenia gravis.